20-November-2026:
The Union Health Ministry on 19 November proposed incorporating Good Storage and Distribution Practices into the Drugs Rules, 1945. The proposal would strengthen accountability as medicines move from manufacturers and importers through warehouses, transporters and stockists. The industry should use the consultation to answer an operational question. Who can establish whether a consignment remained within its required conditions at every handover?
A product can leave a compliant factory and encounter unsuitable storage later. Temperature records may stop at the warehouse door, while an onward journey depends on a different transporter. When a consignment arrives with incomplete records, the receiving pharmacist needs a defined procedure for deciding whether to accept, quarantine or refer it for assessment. Staff should have authority to flag uncertainty without pressure to clear a delivery.
Manufacturers and distributors should agree on responsibilities in their supply contracts. Identify which products need continuous monitoring, retain records through each handover and assign a qualified person to assess departures from specified conditions. Small stockists will need practical training and access to appropriate equipment.
The central and state drug authorities should publish inspection priorities and a proportionate implementation timetable if the proposal is adopted. Monitor whether businesses can retrieve shipment records and resolve questionable consignments. Those checks would show whether quality assurance follows the medicine all the way to its destination.
















